Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Shiga toxin binds to activated platelets.

S A Ghosh1, R K Polanowska-Grabowska, J Fujii

  • 1Department of Biochemistry and Molecular Genetics and Division of Nephrology, School of Medicine, University of Virginia, Charlottesville, VA, USA. sg5g@virginia.edu

Journal of Thrombosis and Haemostasis : JTH
|March 11, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spin-Dependent ππ^{*} Gap in Graphene on a Magnetic Substrate.

Physical review letters·2024
Same author

Correction to "Unveiling the Electronic Structure of Pseudotetragonal WO<sub>3</sub> Thin Films".

The journal of physical chemistry letters·2023
Same author

Unveiling the Electronic Structure of Pseudotetragonal WO<sub>3</sub> Thin Films.

The journal of physical chemistry letters·2023
Same author

Dual pulsed laser deposition system for the growth of complex materials and heterostructures.

The Review of scientific instruments·2023
Same author

Radial Spin Texture of the Weyl Fermions in Chiral Tellurium.

Physical review letters·2020
Same author

An integrated ultra-high vacuum apparatus for growth and in situ characterization of complex materials.

The Review of scientific instruments·2020

Shiga toxin (Stx) binds to activated platelets, not resting ones. This interaction, particularly with EDTA-treated platelets, may explain how Stx causes hemolytic uremic syndrome (HUS) in children.

Area of Science:

  • Microbiology
  • Hematology
  • Pediatric Nephrology

Background:

  • Hemolytic uremic syndrome (HUS) is a severe condition in children, often linked to Shiga toxin (Stx)-producing E. coli.
  • HUS involves acute renal failure, thrombocytopenia, and renal thrombi, suggesting platelet activation in its pathogenesis.
  • The direct role of Shiga toxin in platelet activation remains debated.

Purpose of the Study:

  • To investigate if platelet preparation methods influence Shiga toxin binding.
  • To determine if Shiga toxin directly activates platelets or binds to pre-activated platelets.
  • To explore the role of platelet activation in Shiga toxin-induced HUS.

Main Methods:

  • Comparing Shiga toxin binding to platelets isolated using different anticoagulants and washing procedures (EDTA vs. ACD).

Related Experiment Videos

  • Assessing platelet activation markers (P-selectin/CD62P) and receptor exposure (Gb3) after various treatments.
  • Evaluating morphological changes in platelets post-treatment.

    • Main Results:

    • Platelet binding of Shiga toxin was significantly higher in EDTA-washed preparations compared to ACD-derived platelets.
    • Shiga toxin receptor (Gb3) exposure and platelet activation (P-selectin) were increased on EDTA-treated or thrombin-activated platelets.
    • EDTA-exposed platelets showed altered morphology, becoming larger and losing their discoid shape.

    Conclusions:

    • Direct Shiga toxin binding occurs primarily on activated platelets, not resting platelets.
    • Platelet activation, potentially induced during isolation or by other factors, is crucial for Shiga toxin interaction.
    • These findings offer insights into the pathogenesis of Shiga toxin-induced hemolytic uremic syndrome.